This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Left main coronary artery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. Preliminary evidence from trials focusing on patients with multivessel disease has hinted at diabetes as a potential modifier of treatment outcomes.
a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. TCAR is a minimally invasive, surgical procedure designed to provide best-in-class stroke protection while minimizing adverse events. “As
Background The association between low socioeconomic status (SES) and worse surgical outcomes has become an emerging area of interest. Literature has demonstrated that carotid artery stenting (CAS) poses greater risk of postoperative complications, particularly stroke, than carotid endarterectomy (CEA). 2.30); p = 0.68].
BackgroundThe left subclavian artery (LSA) can be intentionally covered by a stent graft to acquire adequate landing zones for a proximal entry tear near the LSA during thoracic endovascular aortic repair (TEVAR). The Castor single-branched stent graft is designed to treat type B aortic dissection (TBAD) to retain the LSA during TEVAR.
Stroke, Volume 55, Issue Suppl_1 , Page AWP179-AWP179, February 1, 2024. Background:Stent-retriever thrombectomy is the first-line therapy for acute stroke with intracranial large vessel occlusion. In cases of stent-retriever thrombectomy failure, rescue stent angioplasty might be the sole option for achieving permanent recanalization.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerotic disease (ICAD) is associated with up to 32% of posterior circulation strokes.1 1 ICAD‐related strokes are at high risk for re‐occlusion following MT.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP82-ATMP82, February 1, 2025. Introduction:Aspiration and stent retriever thrombectomy are the primary approaches for endovascular management of posterior circulation stroke. However, the optimal first-line choice of surgical technique remains unclear. to -0.40; p < 0.005).
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionIntracranial atherosclerosis (ICAS) is a leading global cause of stroke. The role of intracranial stenting in ICAS remains uncertain. 1‐year rate of stroke and death in stented patients [5].
Stroke, Volume 56, Issue Suppl_1 , Page AWP10-AWP10, February 1, 2025. Background:Increased immediate and delayed re-occlusion rates, up to 33%, are reported in patients undergoing acute stenting for tandem lesions, with symptomatic hemorrhage rates around 10-15%. Larger studies are needed to validate these findings.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP94-AWMP94, February 1, 2025. Introduction:Medical therapy and endovascular therapy for intracranial atherosclerotic disease (ICAD) have evolved over the past two decades with improved medical therapy benchmarks, and improved techniques and patient selection for stenting.
Stroke, Volume 55, Issue Suppl_1 , Page AWP6-AWP6, February 1, 2024. Background:Studies have demonstrated that the addition of alteplase for patients with tandem lesions who underwent mechanical thrombectomy and acute stenting was safe with improved outcomes. Favorable functional outcomes were seen in 80.0%
Stroke, Ahead of Print. BACKGROUND:Carotid artery stenting (CAS) is an alternative treatment for patients with carotid artery stenosis who are not eligible for carotid endarterectomy. Dual antiplatelet therapy (DAPT) after CAS aims to prevent ischemic stroke. However, its optimal duration remains unclear.
This systematic review of the literature aims to explore outcomes in the patients treated with conservative management vs. invasive strategy. SCAD-PCI revascularization frequently required three or more stents and had residual areas of dissection. SCAD-PCI revascularization was associated with a variable range of PCI failure.
Stroke, Volume 56, Issue Suppl_1 , Page ATP226-ATP226, February 1, 2025. Drug-eluting stents have shown better performance than bare metal stents. Patients will be randomized (1:1) to drug-eluting stenting plus medical therapy or medical therapy alone. Results:A total of 472 patients will be enrolled.
Stroke: Vascular and Interventional Neurology, Ahead of Print. Patients were dichotomized into those with 90‐day good functional outcome (modified Rankin scale [mRS] score 0–2) and poor functional outcome (mRS score ≥3). Good functional outcome was observed in 44 patients (40%). < 0.05 versus 83.3%;P versus 62.1%;P
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. In order to improve treatment outcomes in these difficult cases, the use of stent‐assisted embolization has been attempted in endovascular treatment of intracranial aneurysms.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDMechanical thrombectomy is established for large‐vessel occlusions in acute ischemic stroke, but the potential role in distal vessel occlusions of medium arteries is less well established. Arterial diameters were measured at all these sites.
Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment. Periprocedural stroke was defined as <7d from stent placement.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCurrent literature suggests a benefit in functional outcomes and reperfusion rates when carotid artery stenting (CAS) and mechanical thrombectomy (MT) are performed emergently. Stent placement was feasible in all cases.
Stroke, Volume 55, Issue Suppl_1 , Page ATMP94-ATMP94, February 1, 2024. Introduction:Current evidence suggests that acute carotid artery stenting (CAS) for cervical lesions is associated with better functional outcomes in patients with acute stroke with tandem lesions (TLs) treated with endovascular treatment (EVT).
Stroke, Volume 56, Issue Suppl_1 , Page ADP39-ADP39, February 1, 2025. Background:Patients with atrial fibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We There was no difference in post-operative stroke and/or death (10.7%
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionEndovascular thrombectomy has been shown to be beneficial for select patients with medium vessel occlusion ischemic strokes. M2‐M4, ACA, and PCA) who underwent thrombectomy over 5 years (2018‐2022) at a single comprehensive stroke center.
Stroke, Volume 56, Issue Suppl_1 , Page ADP36-ADP36, February 1, 2025. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. All patients had headache, and funduscopic examination demonstrated papilledema for all patients. Additional randomized and controlled clinical research is deserved.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. Transverse sinus stenting is a new effective treatment for IIH. The patient underwent venous sinus stenting for fulminant IIH. The use of ticagrelor did not lead to any adverse outcomes for the patient or the fetus in our case.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. We compared demographics, radiological findings, clinical outcomes, and follow-up results between mismatch and no mismatch groups.Results:Among 73 patients, 20 (27.4%) had DWI-ADC mismatch. DWIR% = (DWIR/baseline DWI volume) 100 was calculated. ml/h vs. 7.5
Stroke: Vascular and Interventional Neurology, Volume 3, Issue 6 , November 1, 2023. BackgroundFor acute proximal intracranial artery occlusions, contact aspiration may be more effective than stent‐retriever for first‐line reperfusion therapy. stent‐retriever versus 55.5% stent‐retriever versus 55.5% versus 23.8%;P=0.10).
Stroke: Vascular and Interventional Neurology, Ahead of Print. OBJECTIVECarotid artery stenting for heavily calcified lesions is challenging for interventionists. A calcium burden is associated with suboptimal dilatation, periprocedural complications, high rates of restenosis, and poor outcomes.
Stroke, Volume 55, Issue Suppl_1 , Page AWP208-AWP208, February 1, 2024. We evaluated patients who underwent emergent carotid artery stenting (CAS) of the ICA with mechanical thrombectomy (MT).Methods:We We evaluated patients who underwent emergent carotid artery stenting (CAS) of the ICA with mechanical thrombectomy (MT).Methods:We
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. 1, 2)These patients are also more likely to experience poor functional outcomes. (3) 3) Rescue stenting (RS) in these patients has shown promising rates of recanalization and better outcomes in preliminary studies.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Herein, we describe a single‐step approach to deploy Neuroform Atlas stent (Stryker Neurovascular, Fremont, CA) which is a hybrid laser‐cut, nitinol self‐expanding stent without the need for ELW or lesion re‐access using MINI TREK RX (Abbott Vascular, Inc.,
Stroke, Volume 56, Issue Suppl_1 , Page ATP253-ATP253, February 1, 2025. Primary outcomes included technical success, with a meta-analysis performed using a random-effects model to calculate proportions and odds ratios (OR) with 95% confidence intervals (Cl).Results:We Results:We included seven studies recruiting 1572 patients.
Stroke: Vascular and Interventional Neurology, Ahead of Print. The primary outcome was the first‐pass effect (FPE), defined as expanded Treatment in Cerebral Infarction (TICI) 2c/3 on the first pass. male, median age 75 (interquartile range 65–82) years, and median National Institutes of Health Stroke Scale score 8 (5–12).
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionMechanical thrombectomy (MT) often fails to achieve successful reperfusion in up to 20% of acute ischemic stroke (AIS) patients with large vessel occlusion (LVO) [1, 2]. ConclusionRS showed promising functional outcomes compared to MM.
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
Stroke: Vascular and Interventional Neurology, Ahead of Print. BACKGROUNDCarotid artery stenting (CAS) has emerged as a viable alternative to carotid endarterectomy for managing carotid artery stenosis in high‐risk patients. There are limited data comparing the outcomes of the transradial with the transfemoral approach for CAS.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP9-AWMP9, February 1, 2024. Introduction:Intracranial atherosclerotic disease (ICAD) is a common cause of ischemic stroke worldwide. In the ICADLVO group, 23 out of 68 patients underwent angioplasty, whereas 38 patients received stenting. vs. 4%, p = 0.008). 1.13, p=0.118).Conclusion:Our
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Diabetes is a risk factor for acute ischemic stroke and also a poor predictor of outcome for many interventional surgeries. vs. 20.5%; p = 0.048) and stenting (28.4% or greater. or greater.
Stroke, Volume 55, Issue Suppl_1 , Page A53-A53, February 1, 2024. Introduction:Mechanical Thrombectomy improves outcomes in patients with acute ischemic stroke due to large vessel occlusion. Data on demographics and baseline risk factors, occlusion site, and acute treatment was pulled from the stroke registry.
Stroke, Volume 55, Issue Suppl_1 , Page AWP187-AWP187, February 1, 2024. Background:Persistent hypotension after carotid artery stenting (CAS) can lead to adverse outcomes, prolong length of stay (LOS), and increase hospital costs. Persistent hypotension prolonged LOS (P=0.014).Conclusion:Prior
Stroke: Vascular and Interventional Neurology, Volume 4, Issue 6 , November 1, 2024. Emergency CEA and carotid stenting procedures were excluded from the analysis. The primary outcome event was the combined inhospital rate of stroke or death. Raw primary outcome event rates were 1.9%, 2.1%, and 1.6%
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionCarotid artery stenting (CAS) has emerged as a viable alternative to carotid endarterectomy for managing carotid artery stenosis in high‐risk patients (1). Limited data exists comparing the outcomes of TR approach in CAS to TF approach.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content